Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Apr 26, 2024

30870_dirs_2024-04-25_15281138-203c-4883-9956-d718d3ff2989.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-04-25

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-25 Common Stock S 10562 $64.54 Disposed 32070 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 83 Indirect

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.